Lunit Inks Partnership with Salud Digna to Travel AI in Clinical Imaging

AI-powered chest X-ray and mammography research answers to be deployed throughout one in all Mexico’s biggest healthcare networks

SEOUL, South Korea, Nov. 27, 2024 /PRNewswire/ — Lunit (KRX:328130.KQ), a well-known supplier of AI-powered answers for most cancers diagnostics and therapeutics, nowadays introduced a strategic partnership with Salud Digna, one in all Mexico’s biggest clinical networks. Beneath the oath, Lunit will ship its AI-powered clinical imaging answers to Salud Digna’s intensive community of over 230 clinics throughout Mexico and Central The us.

The offer facilities on two of Lunit’s flagship merchandise:

Lunit INSIGHT CXR, an AI-powered chest X-ray research answer
Lunit INSIGHT MMG, an AI instrument for mammography research

Those state-of-the-art gear are all set to give a boost to diagnostic functions for Salud Digna, which treats roughly 20 million sufferers yearly.

As a part of the association, Lunit may even achieve get admission to to Salud Digna’s considerable database, comprising thousands and thousands of deidentified 2D mammography and chest X-ray pictures. This high quality information will support Lunit refine its AI algorithms, specifically for the Latin American marketplace.

“By integrating Lunit’s advanced AI into our healthcare network, we aim to improve the accuracy and efficiency of our imaging services,” mentioned Juan Carlos Ordoñez, CEO of Salud Digna. “Together, we are committed to leveraging our extensive data resources to drive innovation in medical imaging and ultimately improve patient care across the region.”

The collaboration extends past a standard supplier-client dating. Lunit and Salud Digna will interact in joint analysis initiatives, leveraging the shared information to additional walk clinical imaging AI era and exhibit the have an effect on of this partnership on healthcare supply in Mexico and around the Latin American pocket.

“This multifaceted partnership with Salud Digna marks a milestone in our global expansion and our mission to improve patient outcomes through AI,” mentioned Brandon Suh, CEO of Lunit. “By combining our cutting-edge AI technology with Salud Digna’s vast clinical experience and extensive patient data, we’re not just supplying software – we’re collaborating to advance medical imaging AI technology tailored to the needs of patients in Mexico and potentially the broader Latin American region.”

About Lunit

Based in 2013, Lunit (KRX:328130.KQ) is a clinical AI corporate on a undertaking to overcome most cancers. We harness AI-powered clinical symbol analytics and AI biomarkers to assure correct analysis and optimum remedy for each and every most cancers affected person. Our FDA-cleared Lunit INSIGHT suite for most cancers screening serves over 4,500 hospitals and clinical establishments throughout 55+ international locations.

Our scientific research had been revealed in supremacy journals, together with the Magazine of Scientific Oncology and the Lancet Virtual Fitness, and introduced at international meetings such because the ASCO and RSNA. In 2024, Lunit bought Volpara Fitness Applied sciences, surroundings the degree for exceptional synergy and accuracy, specifically in breast fitness and screening applied sciences. Headquartered in Seoul, South Korea, with a community of places of work international, Lunit leads the worldwide battle towards most cancers. Uncover extra at lunit.io.

SOURCE Lunit